Related Experiment Videos
Seminal haploid cell detection by flow cytometry in non-obstructive azoospermia: a good predictive parameter for
I Koscinski1, C Wittemer, J M Rigot
1Laboratoire de Biologie de la Reproduction, Hôpital Jeanne de Flandre, 59037 Lille cedex, France. isabelle.koscinski@chru-strasbourg.fr
Human Reproduction (Oxford, England)
|April 30, 2005
Summary
Flow cytometry (FCM) detection of seminal haploid cells can predict testicular sperm extraction (TESE) success in non-obstructive azoospermia (NOA) patients, potentially avoiding invasive testicular biopsies.
Area of Science:
- Reproductive Medicine
- Andrology
- Genetics
Background:
- Non-obstructive azoospermia (NOA) presents challenges for male fertility.
- Testicular sperm extraction (TESE) with ICSI offers a solution, but its success rate is only ~50%.
- Current non-invasive predictors for TESE success are insufficient, necessitating invasive testis biopsies.
Purpose of the Study:
- To evaluate the prognostic value of seminal haploid cell detection using flow cytometry (FCM).
- To determine if FCM can predict testicular sperm extraction (TESE) outcomes in non-obstructive azoospermia (NOA) patients.
- To explore the potential of FCM in avoiding unnecessary testicular biopsies.
Main Methods:
- Study included 37 NOA patients undergoing testicular biopsy.
- Measurements included testis size, serum FSH, and inhibin B levels.
- Seminal cytology, seminal FCM analysis, and histological examination were performed.
Main Results:
- Sperm were recovered in 18 of 37 biopsies.
- Flow cytometry (FCM) demonstrated higher sensitivity (100%) than cytology (59%) for detecting sperm.
- Histological examination showed high specificity (100%) but lower sensitivity (50%).
Conclusions:
- Seminal haploid cell detection by FCM is a promising non-invasive method.
- FCM can effectively predict TESE success in NOA patients.
- This technique may improve the management and reduce invasive procedures for NOA patients.